Psychiatric Case Managers, Psychiatric Mental Health Nurses, Psychiatric Nurses
Recovery, Remission, Schizophrenia, Psychosis, Antipsychotics, Psychotic Disorders, Injectables, Patient Adherence, Patient Compliance,
Schizophrenia is a chronic and severe mental disease that affects 26 million people worldwide, resulting in significant morbidity, an increased risk of mortality, moderate to severe disability in 60% of cases, and an estimated U.S. annual cost of $65 billion. Much of this burden is associated with frequent relapses and hospitalizations, in part because of suboptimally controlled symptoms, medication interventions and follow-through, and an absence of relapse prevention plans. In this activity, expert faculty will follow a mental health consumer through various phases of treatment. Commentary from the mental health consumer will be incorporated throughout the activity in order to provide a unique perspective on the challenges of schizophrenia and insights on how psychiatric mental health nurses can best support optimal outcomes.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This program is approved for 1.5 continuing nursing education contact hours by the American Psychiatric Nurses Association.
Disclosure of Conflicts of Interest
The American Psychiatric Nurses Association (APNA) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by APNA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Lisa Strimple-Padios has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
The following APNA staff serve as clinical content reviewers and/or participate in planning CE activities in a manner that may affect content: Patricia Black, PhD (c), RN; Deborah Hobbs, PhD, RN, hereby state that they or their spouse do not have any financial relationships with any commercial interests related to the content of this CE activity of any amount during the past 12 months.
The following Spire Learning staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content: Kashemi D. Rorie, PhD and Jeanne Prater hereby state that they do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CE activity of any amount during the past 12 months. The spouse of Jeanne Prater, is an employee of Novo Nordisk and stockholder of Johnson & Johnson.
Method of Participation and Request for Credit
There are no additional fees for participating and receiving CE credit for this activity. If you wish to receive full credit for participating in this activity, you must attend the entire session and complete its pre/post-test and evaluation. A CE certificate will be generated online and available for you to print. We cannot award credit unless all steps are completed.
Off-label Product Disclosure
This educational activity does not include the discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration.
General Disclosure and Copyright Statement
The opinions expressed in this activity are those of the participating faculty and not those of the American Psychiatric Nurses Association, Spire Learning or any manufacturers of products mentioned herein.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Copyright 2013. American Psychiatric Nurses Association and Spire Learning. All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the American Psychiatric Nurses Association and Spire Learning.
The American Psychiatric Nurses Association and Spire Learning reserve the right to cancel or modify the activity content, faculty, and activities if necessary.
This educational activity is co-provided by the American Psychiatric Nurses Association and Spire Learning.
This activity is supported by an unrestricted educational grant from Otsuka America Pharmaceutical, Inc.